Medicare GLP-1 Bridge vs your Part D plan: $50 a month for weight loss, outside your plan
The whole program on one page: Medicare GLP-1 Bridge program.
The Bridge is not your Part D plan. It is a CMS program that charges $50 a month for Wegovy, Foundayo or the Zepbound KwikPen for weight loss, through December 31, 2027. Your Part D deductible does not apply, the $50 does not count toward your out-of-pocket total, and the low-income subsidy does not lower it. You still need a Part D plan to use it.
If you do not qualify for the Bridge, two cash programs to check.
No insurance needed.
Prices checked Nov 16, 2026.
- Check price →
- SnagRx$99 a month, billed monthlyBilled monthly. The 12-month plan is $69 a month, billed as $828 up front.compounded semaglutidecompounded tirzepatide $149 a monthCheck price →
- Check price →Eden's GLP-1 page, then an online assessment
The Bridge and your Part D plan, side by side
| Medicare GLP-1 Bridge | Your Part D plan | |
|---|---|---|
| What it pays for | Wegovy, Foundayo and the Zepbound KwikPen, for weight loss | GLP-1s for type 2 diabetes, and for other covered uses on its drug list |
| What you pay | $50 a month, $600 a year | Your plan's copay or coinsurance after any deductible |
| Deductible | Does not apply | Applies, if your plan has one |
| Counts toward your out-of-pocket total | No | Yes |
| Low-income subsidy (Extra Help) | Does not lower it | Lowers your costs if you qualify |
| Who decides | CMS, through a single central processor and a prior authorization | Your plan |
| How long | July 1, 2026 to December 31, 2027 | Each calendar year |
From CMS's Medicare GLP-1 Bridge page, read November 14, 2026.
Which drugs qualify
Wegovy, Foundayo and the Zepbound KwikPen. The Zepbound vials do not qualify, and neither does the Wegovy pill bought at its self-pay price. Type 2 diabetes, moderate to severe sleep apnea and MASH stay with your Part D plan, which already covers a GLP-1 for them.
Who is left out
- Anyone without Medicare Part D coverage.
- Anyone outside the three BMI bands: 35 and over; 30 and over with certain heart, blood pressure or kidney conditions; 27 and over with pre-diabetes, a prior heart attack or stroke, or peripheral artery disease.
- Anyone whose prescriber does not get the prior authorization approved. Check the bands in four questions.
What happens after December 31, 2027
CMS has not said. Its page says the Bridge runs through December 31, 2027, and that it is collecting data on GLP-1 use to share with Part D plans "ahead of potential implementation of BALANCE in Part D". Until CMS announces what follows, plan on the $50 price ending with 2027.
The dates that matter
- October 15 to December 7: Medicare open enrollment. You can join, drop or switch a Part D plan, and the new plan starts January 1 (medicare.gov).
- Any time through December 31, 2027: the Bridge itself. There is no enrollment window; your prescriber starts it with the prescription.
- December 31, 2027: the Bridge's last day, per CMS.
If you have no Part D plan, December 7 is the date that matters: without Part D coverage the Bridge cannot pay for your GLP-1 in 2027.
Frequently asked questions
Is the Medicare GLP-1 Bridge part of my Part D plan?
No. CMS runs it outside the Part D benefit. Your plan does not have to opt in, and it does not pay for the drug. You still need Part D coverage to use it.
How much does the Bridge cost in a year?
$50 a month, or $600 for twelve months. The deductible does not apply, and the copay does not count toward your out-of-pocket total.
Does Extra Help lower the $50?
No. CMS says the low-income subsidy is not provided for drugs under the Bridge.
What happens to the Bridge after 2027?
CMS has not announced a successor. It says it is collecting data ahead of a possible BALANCE model in Part D.
GLP Chart is a comparison site, not a pharmacy and not a medical provider. Confirm the rules with your prescriber and your plan before your next fill.